ACP5 and osteosarcoma: This finding is consistent with previous studies showing that the hypoxic CM from human osteosarcoma cells treated with HIF-1α + HIF-2α siRNAs produced a significant decrease in TRAP-positive multi-nucleated cells and TRAP activity [60].